SweetValueLab
Write for us

Merck & Co., Inc. — Financial Statements & Ratios

MRK
NYSEHealthcareDrug Manufacturers - GeneralCIK 0000310158merck.comAbout MRK
Last close · Oct 16, 2026145.97+0.78 (+0.53%)
Market cap$360.1B

Key indicators

Revenue66.6BTTM+4.6% on a year earlier+6.3% a year, FY2018–FY2025
Fiscal yearFY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025TTMFY2026EFY2027EFY2028E
Growth
42.3B 46.8B+10.7%48.0B+2.5%48.7B+1.5%59.3B+21.7%60.1B+1.4%64.2B+6.7%65.0B+1.3%66.6B+4.6%67.1B 69.8B 73.8B
— 10.7% 2.5% 1.5% 21.7% 1.4% 6.7% 1.3% 4.6% 3.2% 4.0% 5.8%
$2.32 $3.81+64.2%$2.78−27.0%$5.14+84.9%$5.71+11.1%$0.14−97.5%$6.74+4714.3%$7.28+8.0%$1.25−80.7%$2.66 $9.28 $10.22
Profitability
14.7% 21.0%+6.3 pt14.7%−6.3 pt26.8%+12.1 pt24.5%−2.3 pt0.6%−23.9 pt26.7%+26.1 pt28.1%+1.4 pt4.8%−21.0 pt· · ·
23.3% 38.0%+14.7 pt27.9%−10.1 pt34.2%+6.3 pt31.6%−2.6 pt1.0%−30.6 pt37.0%+36.0 pt34.7%−2.3 pt— · · ·
Cash
8.3B 10.0B+20.0%5.6B−44.1%8.7B+55.8%14.7B+69.6%9.1B−37.8%18.1B+97.9%12.4B−31.7%16.1B+9.1%· · ·
19.6% 21.3%+1.6 pt11.6%−9.7 pt17.8%+6.2 pt24.8%+7.0 pt15.2%−9.6 pt28.2%+13.0 pt19.0%−9.2 pt24.1%+1.0 pt· · ·
5.2B 5.7B+10.1%6.2B+9.1%6.6B+6.4%7.0B+6.1%7.4B+6.2%7.8B+5.3%8.2B+4.3%— · · ·
Balance sheet
0.94x 1.02x+0.08x1.26x+0.24x0.87x−0.39x0.67x−0.20x0.93x+0.27x0.80x−0.13x0.94x+0.14x1.29x+0.56x· · ·
2.68B 2.58B−3.7%2.54B−1.5%2.54B−0.1%2.54B+0.2%2.55B+0.2%2.54B−0.2%2.51B−1.3%2.47B−1.7%· · ·

E = analyst consensus (revenue and EPS only). TTM = the twelve months to Jun 30, 2026: the last fiscal year, plus the quarters since, less the same quarters a year earlier. From the 10-K and the 10-Qs since, as accepted by the SEC; the shaded column is the latest period.